Home
Conditions
Bone Marrow Diseases

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 528 recruiting studies

Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment

NCT00499070

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +28 more
Locations: St. Anna Children's Hospital Vienna, Austria

Ghent University Ghent, Belgium

University Hospital Motol Prague, Czechia

Arhus Universitetshospital - Skejby Aarhus, Denmark

View Trial Details

Completed

Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD

NCT00908232

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +20 more
Locations: Bordeaux, France

Le Mans, France

Lille, France

Tours, France

View all 42 locations

View Trial Details

Completed

Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)

NCT00682799

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematopoietic Stem Cell Transplantation (SCT), +5 more
Locations: University Children´s Hospital Frankfurt am Main, Hesse, Germany

View Trial Details

Completed

Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

NCT00002592

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations: University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes

NCT00324194

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: Lee Moffitt Cancer Center Tampa, Florida, United States

University of Chicago Medical Center Chicago, Illinois, United States

Columbia University Medical Center New York, United States

Sir Mortimer Davis Jewish General Hospital Montreal, Quebec, Canada

View Trial Details

Completed

A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes

NCT00324129

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: Anderson Cancer Center Houston, Texas, United States

Princess Margaret Hospital Toronto, Ontario, Canada

Sir Mortimer Davis-Jewish General Hospital Montreal, Quebec, Canada

View Trial Details

Completed

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

NCT00381550

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blast Crisis, +37 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to Gleevec

NCT00661180

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations: Portland, Oregon, United States

Lyon, France

Paris, France

Poitiers, France

View Trial Details

Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

NCT00351975

Conditions: Accelerated Phase of Disease, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +47 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

Princess Margaret Hospital Cashmere, Canterbury, New Zealand

View Trial Details

Completed

A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

NCT00283114

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +16 more
Locations: Rocky Mountain Cancer Center Denver, Colorado, United States

Cancer Care Specialists of Central Illinois Decatur, Illinois, United States

Indiana Oncology-Hematology Consultants Indianapolis, Indiana, United States

University of Massachusetts Medical Center Worcester, Massachusetts, United States

View Trial Details

Bone Marrow Diseases

Bone Marrow Diseases trial results

Related conditions